市场调查报告书
商品编码
1451412
按产品类型(手动、自动)、样本类型(血液、胚胎、卵子、精液)、最终用户(血库、医院、组织库、製药和生物技术公司等)和地区分類的医疗解冻系统市场报告 2024- 2032Medical Thawing System Market Report by Product Type (Manual, Automated), Sample Type (Blood, Embryo, Ovum, Semen), End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical and Biotech Companies, and Others), and Region 2024-2032 |
2023年,全球医用解冻系统市场规模达到2.055亿美元。展望未来, IMARC Group预计到2032年市场规模将达到3.728亿美元,2024-2032年复合年增长率(CAGR)为6.63%。慢性病盛行率的不断上升、对再生和个人化药物的需求不断增长以及持续的技术进步是推动市场发展的一些关键因素。
医用解冻系统用于医疗机构安全快速地解冻血液製品、疫苗和组织样本等冷冻生物标本。它采用受控过程,在水浴中加热和搅拌冷冻样本,使其均匀解冻,而不会对样本造成任何损坏。除此之外,它们还有助于最大限度地降低污染风险,确保检测结果准确可靠,并降低处理冷冻标本的医护人员受伤的风险。医用解冻系统符合处理生物材料的严格监管标准,对于确保解冻标本的品质和功效至关重要。因此,它作为可靠、高效和标准化的设备广泛应用于各种医疗机构,以确保患者护理和研究中使用的生物样本的品质和功效。
患有慢性疾病以及病毒和细菌感染的人数不断增加是推动市场成长的主要因素之一。与此一致的是,器官移植倾向的不断增强和器官捐赠者的增加,加上输血需求的激增,正在为市场创造良好的前景。除此之外,对再生医学的需求不断扩大,推动了对干细胞、组织和其他生物样本安全有效解冻的需求,这反过来又促进了市场的成长。此外,创新技术的进步,例如自动化和机器人技术的集成,以提高解冻系统的效率和准确性,正在为市场带来丰厚的成长机会。此外,COVID-19病毒的爆发推动了组织标本的收集,以研究感染的生物学影响并确定新的治疗干预措施和预防策略,这对市场成长产生了积极影响。其他因素,例如老年人口不断增加、医疗保健支出增加、参与捐血活动的人数不断增加、对个性化药物的需求不断增加,以及为开发治疗罕见疾病的有效疗法而对研发(R&D) 项目进行的大量投资,正在加强市场成长。
The global medical thawing system market size reached US$ 205.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 372.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market.
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, sample type and end user.
Manual
Automated
The report has provided a detailed breakup and analysis of the medical thawing system market based on the product type. This includes manual and automated. According to the report, the manual represented the largest segment.
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
A detailed breakup and analysis of the medical thawing system market based on the sample type has also been provided in the report. This includes blood (plasma, stem cells, whole blood and platelets), embryo, ovum and semen. According to the report, blood accounted for the largest market share.
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
The report has provided a detailed breakup and analysis of the medical thawing system market based on the end-user. This includes blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. According to the report, blood banks represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.